Crucially, the extract exhibited potent dual cholinesterase inhibition, with an IC50 of 4.87 μg/mL (AChE) and 40.99 μg/mL (BChE), suggesting its ability to enhance cholinergic neurotransmission—a key therapeutic target in AD. Here, BCHE is linked to Alzheimer disease.